Vote Scores

Home / Companies / Spectrum Pharmaceuticals, Inc. / 27 Jul 2023

Meeting · year to 30 June 202481 filers reporting

Spectrum Pharmaceuticals, Inc.: meeting of 27 Jul 2023

Votes reported on Form N-PX, item by item

81 Form N-PX filers reported votes at the Spectrum Pharmaceuticals, Inc. meeting of 27 Jul 2023. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on pay tied to a merger or sale

95 vote records from 79 filers. 61 of the 74 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.

16.5% for77.2% against6.3% other82.4% against management79 filers1.5% for98.5% against0.0% other98.5% against management1,269,280,782 reported shares
2

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

23 vote records from 17 filers. 0 of the 17 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management17 filers100.0% for0.0% against0.0% against management12,012,844 reported shares, counted once per item in this group
3

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

33 vote records from 20 filers. 2 of the 20 filers that marked the item either way voted against management.

90.0% for10.0% against10.0% against management20 filers86.8% for13.2% against13.2% against management12,108,806 reported shares, counted once per item in this group

How the largest families voted

Family1. Merger pay
VanguardAgainst *
BlackRock and iSharesAgainst *
FidelityAgainst *
DimensionalAgainst *
State Street and SPDRAgainst *
Franklin TempletonAgainst *
Charles SchwabAgainst *
John Hancock and ManulifeAgainst *
Morgan Stanley, Eaton Vance and CalvertAgainst *
Goldman SachsAgainst *
PGIM and PrudentialAgainst *
Jackson National fundsAgainst *
Northern Trust and FlexSharesAgainst *
Lincoln FinancialAgainst *
NationwideAgainst *
Victory CapitalAgainst *
Guggenheim and RydexAgainst *
Columbia ThreadneedleAgainst *
BNY MellonAgainst *
Janus HendersonAgainst *
BairdAgainst *

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Spectrum Pharmaceuticals, Inc. meeting?

81 Form N-PX filers reported votes at the meeting of 27 Jul 2023. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Spectrum Pharmaceuticals, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Spectrum Pharmaceuticals, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Spectrum Pharmaceuticals, Inc. with a meeting date within three days of 27 Jul 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.